These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 22304763)
1. [Immune response to HBsAg can not be enhanced with B7-H1 protein vaccine]. Su WJ; Zhang Y; Liu B; Lian JQ; Huang CX; Bai XF Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Feb; 28(2):113-6. PubMed ID: 22304763 [TBL] [Abstract][Full Text] [Related]
2. Diverse immune responses to HBV surface epitope variants after vaccine booster in adolescents immunized in infancy. Lai MW; Liang KH; Yeh CT Clin Microbiol Infect; 2019 Sep; 25(9):1140-1146. PubMed ID: 30771531 [TBL] [Abstract][Full Text] [Related]
3. Humoral and cellular immune responses to hepatitis B vaccination in hepatitis B surface antigen-carrier children who cleared serum-hepatitis B surface antigen. Hsu HY; Chang MH; Hsieh RP; Ni YH; Chi WK Hepatology; 1996 Dec; 24(6):1355-60. PubMed ID: 8938161 [TBL] [Abstract][Full Text] [Related]
4. Mechanism of action of vaccine therapy in murine hepatitis B virus carriers: vaccine-induced activation of antigen presenting dendritic cells. Akbar SM; Abe M; Masumoto T; Horiike N; Onji M J Hepatol; 1999 May; 30(5):755-64. PubMed ID: 10365798 [TBL] [Abstract][Full Text] [Related]
5. HBV DNA vaccine with adjuvant cytokines induced specific immune responses against HBV infection. Du DW; Jia ZS; Li GY; Zhou YY World J Gastroenterol; 2003 Jan; 9(1):108-11. PubMed ID: 12508362 [TBL] [Abstract][Full Text] [Related]
6. Blockade of B7-H1 enhances dendritic cell-mediated T cell response and antiviral immunity in HBV transgenic mice. Jiang W Vaccine; 2012 Jan; 30(4):758-66. PubMed ID: 22133510 [TBL] [Abstract][Full Text] [Related]
7. IL-12-based vaccination therapy reverses liver-induced systemic tolerance in a mouse model of hepatitis B virus carrier. Zeng Z; Kong X; Li F; Wei H; Sun R; Tian Z J Immunol; 2013 Oct; 191(8):4184-93. PubMed ID: 24048897 [TBL] [Abstract][Full Text] [Related]
8. TH1 and TH2 responses are influenced by HLA antigens in healthy neonates vaccinated with recombinant hepatitis B vaccine. Jafarzadeh A; Shokri F Iran J Allergy Asthma Immunol; 2012 Dec; 11(4):308-15. PubMed ID: 23264407 [TBL] [Abstract][Full Text] [Related]
9. [Suppression of the antigen-specific T cell immune response by co-immunization with the HBV DNA vaccine and recombinant HBsAg]. Du X; Wang J; Kang Y; Xiao W; Zhao G; Wang B Wei Sheng Wu Xue Bao; 2009 Jul; 49(7):938-42. PubMed ID: 19873759 [TBL] [Abstract][Full Text] [Related]
10. Nasal route favors the induction of CD4 Bourgine M; Crabe S; Lobaina Y; Guillen G; Aguilar JC; Michel ML Antiviral Res; 2018 May; 153():23-32. PubMed ID: 29510155 [TBL] [Abstract][Full Text] [Related]
11. Whole recombinant Hansenula polymorpha expressing hepatitis B virus surface antigen (yeast-HBsAg) induces potent HBsAg-specific Th1 and Th2 immune responses. Bian G; Cheng Y; Wang Z; Hu Y; Zhang X; Wu M; Chen Z; Shi B; Sun S; Shen Y; Chen EJ; Yao X; Wen Y; Yuan Z Vaccine; 2009 Dec; 28(1):187-94. PubMed ID: 19789093 [TBL] [Abstract][Full Text] [Related]
12. The new nano-complex, Hep-c, improves the immunogenicity of the hepatitis B vaccine. Fakharzadeh S; Kalanaky S; Hafizi M; Goya MM; Masoumi Z; Namaki S; Shakeri N; Abbasi M; Mahdavi M; Nazaran MH Vaccine; 2013 May; 31(22):2591-7. PubMed ID: 23583463 [TBL] [Abstract][Full Text] [Related]
13. Hepatitis B surface antigen (HBsAg) and core antigen (HBcAg) combine CpG oligodeoxynucletides as a novel therapeutic vaccine for chronic hepatitis B infection. Li J; Ge J; Ren S; Zhou T; Sun Y; Sun H; Gu Y; Huang H; Xu Z; Chen X; Xu X; Zhuang X; Song C; Jia F; Xu A; Yin X; Du SX Vaccine; 2015 Aug; 33(35):4247-54. PubMed ID: 25858855 [TBL] [Abstract][Full Text] [Related]
14. Oral administration of synthetic selenium nanoparticles induced robust Th1 cytokine pattern after HBs antigen vaccination in mouse model. Mahdavi M; Mavandadnejad F; Yazdi MH; Faghfuri E; Hashemi H; Homayouni-Oreh S; Farhoudi R; Shahverdi AR J Infect Public Health; 2017; 10(1):102-109. PubMed ID: 27026241 [TBL] [Abstract][Full Text] [Related]
15. A mouse model with age-dependent immune response and immune-tolerance for HBV infection. Yi X; Yuan Y; Li N; Yi L; Wang C; Qi Y; Gong L; Liu G; Kong X Vaccine; 2018 Feb; 36(6):794-801. PubMed ID: 29306503 [TBL] [Abstract][Full Text] [Related]
16. A novel dendritic-cell-targeting DNA vaccine for hepatitis B induces T cell and humoral immune responses and potentiates the antivirus activity in HBV transgenic mice. Yu D; Liu H; Shi S; Dong L; Wang H; Wu N; Gao H; Cheng Z; Zheng Q; Cai J; Zou L; Zou Z Immunol Lett; 2015 Dec; 168(2):293-9. PubMed ID: 26475398 [TBL] [Abstract][Full Text] [Related]
17. Poly(I:C)/alum mixed adjuvant priming enhances HBV subunit vaccine-induced immunity in mice when combined with recombinant adenoviral-based HBV vaccine boosting. Chuai X; Chen H; Wang W; Deng Y; Wen B; Ruan L; Tan W PLoS One; 2013; 8(1):e54126. PubMed ID: 23335993 [TBL] [Abstract][Full Text] [Related]
18. Effect of the hepatitis B virus S‑ecdCD40L vaccine therapy in HBV transgenic mice: A vaccine‑induced activation of antigen presenting dendritic cells. Guan H; Lan S; Wu J; Tang B; Xu Y Mol Med Rep; 2017 Nov; 16(5):6102-6108. PubMed ID: 28849136 [TBL] [Abstract][Full Text] [Related]
19. Posintro™-HBsAg, a modified ISCOM including HBsAg, induces strong cellular and humoral responses. Schiött A; Larsson K; Manniche S; Kalliomäki S; Heydenreich AV; Dalsgaard K; Kirkby N Int J Pharm; 2011 Jul; 414(1-2):312-20. PubMed ID: 21601626 [TBL] [Abstract][Full Text] [Related]
20. [Reciprocal priming-boosting role of HBsAg and DNA vaccines]. Zhou Z; Chen WS; Zhang HH; Yao JL Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):212-4. PubMed ID: 12716517 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]